Osteoporosis and spinal fractures in men with prostate cancer: risk factors and effects of androgen deprivation therapy

The Journal of Urology
T H DiamondC Bryant

Abstract

We determined the risk factors for osteoporosis and spinal fractures in men with prostate cancer receiving androgen deprivation therapy. We performed a retrospective analysis of 87 consecutive men with prostate cancer receiving androgen deprivation therapy referred for evaluation of osteoporosis. Data were comprised of lateral thoracolumbar radiographs, bone densitometry, serum biochemistry and a detailed assessment of osteoporotic risk factors. Multivariate regression analysis was used to determine the major risk factors for osteoporosis and spinal fractures. There were 38 (44%) men who were 74.5 years old with radiographic evidence of spinal fractures. They had an initial mean prostate specific antigen of 52.8 ng/ml and had received androgen deprivation therapy for a mean of 39.6 months (95% confidence interval 28.7 to 50.4). Mean spinal (quantitative computerized tomography t-score -4.2) and femoral neck bone mineral densities (dual energy x-ray absorptiometry t-score -2.1) were significantly lower than in men without spinal fractures (p < 0.001 for all measurements). In the regression analysis the duration of androgen deprivation therapy (p = 0.002), serum 25-hydroxyvitamin D levels (p = 0.003) and a history of alcohol exce...Continue Reading

References

Sep 1, 1993·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·H K GenantM C Nevitt
Sep 25, 1997·The Journal of Urology·A KrongradB A Roos
Dec 22, 1999·The Journal of Urology·H W DaniellP T Stratte
Jul 14, 2000·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·J M ZmudaJ S Finkelstein
Jun 9, 2001·The Journal of Clinical Endocrinology and Metabolism·S A StochS L Greenspan
Sep 29, 2001·The New England Journal of Medicine·M R SmithJ S Finkelstein
Jul 20, 2002·The Journal of Urology·Jackson E FowlerWilliam L Duncan
Oct 3, 2002·Journal of the National Cancer Institute·Fred SaadUNKNOWN Zoledronic Acid Prostate Cancer Study Group
Apr 11, 2003·The Journal of Urology·L Joseph MeltonHorst Zincke

❮ Previous
Next ❯

Citations

Feb 16, 2008·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Lene ThorsenSophie D Fosså
Oct 5, 2010·Journal of Cancer Survivorship : Research and Practice·Gunhild Maria GjersetLene Thorsen
Jun 28, 2006·Prostate Cancer and Prostatic Diseases·N D JamesC Luscombe
May 21, 2010·BMC Urology·Ary Serpa NetoAuro Del Giglio
Jun 4, 2011·Genetics and Molecular Biology·Marciane MagnaniIlce Mara de Syllos Cólus
Mar 2, 2013·Indian Journal of Urology : IJU : Journal of the Urological Society of India·Manas R PradhanRakesh Kapoor
Oct 23, 2013·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Maria E Suarez-AlmazorLinda S Elting
Oct 23, 2013·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·R RizzoliUNKNOWN International Osteoporosis Foundation Committee of Scientific Advisors Working Group on Cancer-Induced Bone Disease
May 30, 2014·Endocrine-related Cancer·Carolyn A AllanKati L Matthiesson
Dec 9, 2004·Current Opinion in Urology·Scott M Gilbert, James M McKiernan
Feb 15, 2013·The Journal of Sexual Medicine·Landon W TrostWayne J G Hellstrom
Sep 6, 2011·Endocrinology and Metabolism Clinics of North America·Mathis Grossmann, Jeffrey D Zajac
Jul 5, 2011·Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry·Sarah SullivanSusan L Greenspan
Jun 16, 2010·Revista clínica española·M J Moro-Alvarez, J A Blázquez Cabrera
Apr 30, 2008·Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry·John T SchousboeNeil Binkley
Apr 25, 2006·The Urologic Clinics of North America·Scott M Gilbert, James M McKiernan
Oct 4, 2007·Journal of the American Geriatrics Society·Jennifer Grossman, Catherine H MacLean
Jan 25, 2006·European Urology·Fred SaadMarc Colombel
Nov 10, 2015·Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznań and Polish Society of Radiation Oncology·Pilar Ma Samper OtsMa Magdalena Márquez García-Salazar
Aug 29, 2013·ISRN Urology·Petros Sountoulides, Thomas Rountos
Jan 30, 2007·Expert Opinion on Pharmacotherapy·Mack Roach, Alejandra Izaguirre
Oct 27, 2006·Clinical Journal of Oncology Nursing·Susan Doyle-Lindrud
Jun 22, 2005·Cancer Treatment Reviews·Ignazio CarrecaMartine Extermann
Aug 22, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Milena Braga-BasariaShehzad Basaria
Oct 29, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Fred SaadKathleen I Pritchard
Jul 9, 2008·Acta Oncologica·Peter VestergaardLeif Mosekilde
Jun 27, 2012·Prostate Cancer and Prostatic Diseases·K A BolamD R Taaffe
Jan 22, 2018·Calcified Tissue International·Catherine HandforthJanet Brown
Sep 29, 2005·The Journal of Clinical Endocrinology and Metabolism·Susan L GreenspanNeil M Resnick
May 21, 2015·Revista do Colégio Brasileiro de Cirurgiões·Bruno Lopes CançadoMaria Lucia Fleiuss Farias
Feb 1, 2018·Journal of Molecular Endocrinology·Sang R LeeEui-Ju Hong
Sep 29, 2020·The Proceedings of the Nutrition Society·Aoife M Ryan, Erin S Sullivan
Feb 24, 2006·The Medical Journal of Australia·D Jane Holmes-WalkerDavid R Chipps

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.